PDL BioPharma Inc. | Mutual Funds
Mutual Funds that own PDL BioPharma Inc.
Vanguard Total Stock Market Index Fund
4,756,420
3.27%
622,226
0%
07/31/2018
SPDR S&P Biotech ETF
4,331,692
2.98%
11,145
0.18%
09/06/2018
Vanguard Small Cap Index Fund
3,611,726
2.48%
63,069
0.01%
07/31/2018
DFA US Small Cap Value Portfolio
3,298,747
2.27%
63,162
0.04%
04/30/2018
iShares Russell 2000 ETF
3,181,518
2.19%
-1,698
0.02%
09/06/2018
IG Mackenzie Canadian Equity Growth Fund
3,152,600
2.17%
249,200
0.75%
03/31/2018
Vanguard Small Cap Value Index Fund
2,247,395
1.55%
11,884
0.02%
07/31/2018
Vanguard Extended Market Index Fund
2,034,839
1.4%
0
0.01%
07/31/2018
iShares Nasdaq Biotechnology ETF
1,736,845
1.2%
-22,701
0.04%
09/06/2018
Northern Small Cap Value Fund
1,502,758
1.03%
729,794
0.1%
03/31/2018
| Address |
932 Southwood Boulevard
Incline Village Nevada 89451
United States
|
|
Employees
|
- |
| Website |
http://www.pdl.com |
| Updated |
07/08/2019 |
| PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. |
